246 related articles for article (PubMed ID: 8558017)
1. Oral antigen inhibits priming of CD8+ CTL, CD4+ T cells, and antibody responses while activating CD8+ suppressor T cells.
Ke Y; Kapp JA
J Immunol; 1996 Feb; 156(3):916-21. PubMed ID: 8558017
[TBL] [Abstract][Full Text] [Related]
2. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses.
Ke Y; Li Y; Kapp JA
Eur J Immunol; 1995 Feb; 25(2):549-53. PubMed ID: 7875219
[TBL] [Abstract][Full Text] [Related]
3. Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin.
Melamed D; Friedman A
Eur J Immunol; 1993 Apr; 23(4):935-42. PubMed ID: 8458379
[TBL] [Abstract][Full Text] [Related]
4. Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo.
Ishioka GY; Colon S; Miles C; Grey HM; Chesnut RW
J Immunol; 1989 Aug; 143(4):1094-100. PubMed ID: 2787356
[TBL] [Abstract][Full Text] [Related]
5. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
6. Genetically engineered fibroblasts with antigen-presenting capability: efficient induction of an antigen-specific cytotoxic T-lymphocyte response and protection against tumor development in vivo.
Kim TS; Chung SW; Kim SH; Kang BY; Hwang SY; Lee JW
Cancer Gene Ther; 2000 Jun; 7(6):861-9. PubMed ID: 10880016
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
8. Oral immunization with enterocoated microbeads induces antigen-specific cytolytic T-cell responses.
Vogel K; Kantor J; Wood L; Rivera R; Schlom J
Cell Immunol; 1998 Nov; 190(1):61-7. PubMed ID: 9826447
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
Maecker HT; Umetsu DT; DeKruyff RH; Levy S
J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the primary in vitro response to TNP-polymerized ovalbumin by T suppressor cells induced by ovalbumin feeding.
Cowdery JS; Johlin BJ
J Immunol; 1984 Jun; 132(6):2783-9. PubMed ID: 6233361
[TBL] [Abstract][Full Text] [Related]
11. Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance.
Ke Y; Pearce K; Lake JP; Ziegler HK; Kapp JA
J Immunol; 1997 Apr; 158(8):3610-8. PubMed ID: 9103422
[TBL] [Abstract][Full Text] [Related]
12. Priming MHC-I-restricted cytotoxic T lymphocyte responses to exogenous hepatitis B surface antigen is CD4+ T cell dependent.
Wild J; Grusby MJ; Schirmbeck R; Reimann J
J Immunol; 1999 Aug; 163(4):1880-7. PubMed ID: 10438922
[TBL] [Abstract][Full Text] [Related]
13. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses.
Newman MJ; Wu JY; Gardner BH; Munroe KJ; Leombruno D; Recchia J; Kensil CR; Coughlin RT
J Immunol; 1992 Apr; 148(8):2357-62. PubMed ID: 1373166
[TBL] [Abstract][Full Text] [Related]
14. Soluble protein but not peptide administration diverts the immune response of a clonal CD4+ T cell population to the T helper 2 cell pathway.
Degermann S; Pria E; Adorini L
J Immunol; 1996 Oct; 157(8):3260-9. PubMed ID: 8871620
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of specific immune responses by feeding protein antigens. V. Induction of the tolerant state in the absence of specific suppressor T cells.
Hanson DG; Miller SD
J Immunol; 1982 May; 128(5):2378-81. PubMed ID: 6460822
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific suppressor factors of noncytotoxic CD8+ suppressor T cells downregulate antibody responses also to unrelated antigens when the latter are presented as covalently linked adducts with the specific antigen.
Bitoh S; Takata M; Maiti PK; Holford-Strevens V; Kierek-Jaszczuk D; Sehon AH
Cell Immunol; 1993 Aug; 150(1):168-93. PubMed ID: 8343965
[TBL] [Abstract][Full Text] [Related]
17. Effect of in vivo depletion of CD4+ and CD8+ cells on the induction and maintenance of oral tolerance.
Barone KS; Jain SL; Michael JG
Cell Immunol; 1995 Jun; 163(1):19-29. PubMed ID: 7758127
[TBL] [Abstract][Full Text] [Related]
18. Mucosally induced systemic T cell unresponsiveness to ovalbumin requires CD40 ligand-CD40 interactions.
Kweon MN; Fujihashi K; Wakatsuki Y; Koga T; Yamamoto M; McGhee JR; Kiyono H
J Immunol; 1999 Feb; 162(4):1904-9. PubMed ID: 9973457
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of specific immune responses by feeding protein antigens. IV. Evidence for tolerance and specific active suppression of cell-mediated immune responses to ovalbumin.
Miller SD; Hanson DG
J Immunol; 1979 Nov; 123(5):2344-50. PubMed ID: 90707
[TBL] [Abstract][Full Text] [Related]
20. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber-associated immune deviation.
Kezuka T; Streilein JW
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1803-11. PubMed ID: 10845601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
